Inventor · disambiguated record
Robert H. Mazur
Also filed as: MAZUR ROBERT H
14 granted patents·142 citations·filing 1974–1989
92Inventor score
Top patents by PatentIndex Score
14 records- 0192US4273704AN-Adamantane-substituted tetrapeptide amidesSEARLE & CO·Filed 1979·Granted Jun 16, 1981·48 cites·17 claims
- 0272US4028319A2 and 3-substituted enkephalinsSEARLE & CO·Filed 1976·Granted Jun 7, 1977·12 cites·23 claims
- 0363US4495178AEnkephalin analogsSEARLE & CO·Filed 1983·Granted Jan 22, 1985·8 cites·50 claims
- 0463US4407746ACyclohexyl and phenyl substituted enkephalinsSEARLE & CO·Filed 1981·Granted Oct 4, 1983·13 cites·9 claims
- 0560US5137904AThiohydantoin inhibitors of collagen-induced and ADP-induced platelet aggregationSEARLE & CO·Filed 1989·Granted Aug 11, 1992·7 cites·23 claims
- 0657US4012367AAnti-ulcer polypeptides containing L-aspartic acid and intermediates theretoSEARLE & CO·Filed 1976·Granted Mar 15, 1977·11 cites·11 claims
- 0751US4204991ASarcosine1 dehydroalanine8 angiotensin II derivativesSEARLE G D &·Filed 1979·Granted May 27, 1980·7 cites·4 claims
- 0849US4599325ASubstituted tyrosyl alanine dipeptide amidesSEARLE & CO·Filed 1985·Granted Jul 8, 1986·14 cites·26 claims
- 0947US3975365AInhibitory octapeptides angiotensin IISEARLE & CO·Filed 1975·Granted Aug 17, 1976·6 cites·14 claims
- 1045US4603121AEnkephalin analogsSEARLE & CO·Filed 1984·Granted Jul 29, 1986·6 cites·15 claims
- 1139US4722922ATetrapeptide amides in the treatment of hypertensionSEARLE & CO·Filed 1985·Granted Feb 2, 1988·4 cites·14 claims
- 1234US4727189ASubstituted tyrosyl alanine dipeptide amidesSEARLE & CO·Filed 1986·Granted Feb 23, 1988·2 cites·4 claims
- 1332US4011260A3-amino-n-substituted succinamic acids and intermediates theretoSEARLE & CO·Filed 1974·Granted Mar 8, 1977·4 cites·5 claims
- 1429US4025551A3-Amino-N-substituted succinamic acidsSEARLE & CO·Filed 1975·Granted May 24, 1977·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Robert H. Mazur files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →